Intelligent Medicine has been named to the 2025 list of China’s Internationally Influential Excellent Academic Journals, ranking 66th, following the release of the China Academic Journal International Citation Annual Report (2025). The recognition highlights the journal’s growing international reach in bridging artificial intelligence, data science, digital technology, and clinical medicine.
The annual report, co-released by CNKI and the Tsinghua University Library, is a key benchmark of global reach for Chinese scholarship. The 2025 analysis evaluated 7,240 Chinese journals based on citations from 27,117 international source journals indexed in Web of Science, Scopus, EI, and Medline. More than 3 million international citations were documented in the past year, underscoring the significance of Intelligent Medicine’s inclusion among the top tier.
Intelligent Medicine’s growth is underpinned by its editorial leadership and publishing model. The journal is led by Editor-in-Chief Professor Jiahong Dong, MD, PhD, an Academician of the Chinese Academy of Engineering, Dean of the Tsinghua University School of Clinical Medicine, and President of Beijing Tsinghua Changgung Hospital. His vision is supported by an international editorial board of more than 60 experts from Asia, North America, Europe, and Oceania, covering disciplines including intelligent surgery, medical imaging, health data science, and AI ethics. This structure ensures rigorous peer review and a multidisciplinary perspective.
The journal is sponsored by the Chinese Medical Association and published in partnership with Elsevier as a fully open-access title. Intelligent Medicine is indexed in DOAJ, ESCI, EI, Scopus, ScienceDirect, and other major services. According to the journal’s official Insights page, it reports an Impact Factor of 6.9 (JCR 2025) and a CiteScore of 10.1 (Scopus), reflecting its performance across medical informatics and related fields.
Building on this momentum, Intelligent Medicine invites submissions that translate intelligent technologies into real-world healthcare impact, including clinical AI, health data science, medical informatics, and intelligent devices. The journal emphasizes implementation studies, prospective and real-world validation, and practice-shaping reviews. Article types include Research Articles, Reviews, Editorials, Perspectives, Case Reports, and Letters.
To lower barriers for contributors worldwide, the Article Publishing Charge (APC) is covered for all articles submitted by December 31, 2025, ensuring immediate open access upon acceptance.
In parallel with its international expansion, Intelligent Medicine also welcomes expressions of interest from established scholars to join its Editorial Board and contribute to advancing interdisciplinary, translational research at the intersection of technology and medicine.
***
About Intelligent Medicine
Intelligent Medicine (ISSN 2667-1026) is a fully open-access journal publishing high-quality research on the application of artificial intelligence, data science, and intelligent technologies in clinical medicine, biomedicine, and public health. The journal is sponsored by the Chinese Medical Association and published in partnership with Elsevier.
Website: https://www.sciencedirect.com/journal/intelligent-medicine
Journal
Intelligent Medicine
Method of Research
Commentary/editorial